N.L. Health Authority Lacked Quality Controls: Lawyer in Breast Cancer Suit
Posted on: Wednesday, 23 May 2007, 15:00 CDT
ST. JOHN'S, N.L. (CP) - A lawyer representing breast cancer patients behind a lawsuit against a Newfoundland health authority says a lack of quality controls, among other things, justifies the class action against the organization.
During a hearing today to certify the class action, Ches Crosbie said the Eastern Health authority failed to properly supervise and train staff, as well as inform patients in a timely manner of inaccurate breast cancer test results.
About 20 clients represented by Crosbie attended the first day of the three-day certification hearing in a St. John's courtroom.
The allegations in their statement of claim have not been proven in court.
The lawsuit was launched after it was discovered that more than 300 patients received the wrong results from their breast cancer tests from 1997 to 2005.
The provincial government has announced a judicial inquiry to determine how so many patients could have received the wrong results.
Source: Canadian Press
Related Articles
- New Study Reports Improved Patient Outcomes for Breast Cancer Patients
- Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
- CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients With Advanced Breast Cancer
- CLSI Publishes Guideline for Verification of Comparability of Patient Results Within One Health Care System
- Immutep Presents Encouraging Results From Breast Cancer Study
- Survey Reveals Patients Prefer New Breast Exam From Advanced Imaging Technologies
- St. Louis Cancer & Breast Institute Physician Says Hormone Replacement Therapy Does Indeed Create Breast Cancer Risk
- CellSearch(TM) Circulating Tumor Cell Kit Receives FDA Clearance for Monitoring Patients With Metastatic Breast Cancer
- Alzheimer's patients get less breast cancer therapy
- AmpliMed Begins Patient Enrollment for Phase I Trial of Amplimexon(TM) Plus Docetaxel in Patients With Lung, Breast and Prostate Cancer
 |
 |
User Comments (0)
RSS Feeds